Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | Neurological risks of laughing gas abuse

Anne Bruijnes • 1 Jun 2020
EAN 2020
General

Anne Bruijnes, MD, Zuyderland Medical Center, Heerlen, The Netherlands, discusses the neurological outcomes associated with recreational use of laughing gas (nitrous oxide). This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

Related Videos

A discussion at EAN 2026 on the impact of climate change on neurological diseases
13:26
A discussion at EAN 2026 on the impact of climate change on neurological diseases
Amalia Ghergu et al. • 28 Jun 2026
Medically assisted dying and palliative care in neurological disorders
1:39
Medically assisted dying and palliative care in neurological disorders
Katarina Rukavina • 20 Apr 2026
Skin biopsy in long COVID: LCCS study findings on neuropathy and persistent anosmia
2:42
Skin biopsy in long COVID: LCCS study findings on neuropathy and persistent anosmia
Christopher Gibbons • 21 Apr 2026
Using VJNeurology to stay updated with research advances
0:38
Using VJNeurology to stay updated with research advances
Ana Catarina Fonseca • 5 Feb 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals